Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 173 clinical trials
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

aspirin
anticoagulants
warfarin
rivaroxaban
embolism
Sinai Hospital
 (7.7 away) Contact site
  • 324 views
  • 07 Sep, 2020
  • +34 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

pembrolizumab
adenocarcinoma
pemetrexed
tumor cells
metastasis
Northwest Hospital Center
 (3.8 away) Contact site
  • 1103 views
  • 29 Nov, 2020
  • +1097 other locations
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo, in the treatment of participants in heart failure with iron deficiency and with a reduced ejection fraction.

nesiritide
b-type natriuretic peptide
cardiac resynchronization therapy
natriuretic peptide
nt-probnp
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 5316 views
  • 05 Nov, 2020
  • +326 other locations
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

This is a modular, phase I/ phase 1 b, open-label, multicentre study of ceralasertib administered orally in combination with cytotoxic chemotherapy regimens and/or novel anti-cancer agents, to patients with advanced malignancies. The study design allows an investigation of optimal combination dose of ceralasertib with other anti-cancer treatments, with intensive safety …

Research Site
 (7.6 away) Contact site
  • 64 views
  • 11 Nov, 2020
  • +20 other locations
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

The purpose of this study is to determine the long-term safety of RPC1063 for the treatment of all patients with moderate to severe Ulcerative Colitis (UC) as well as the long-term efficacy of RPC1063 for the treatment of adult patients with moderate to severe UC. Additionally, to determine the long-term …

endoscopy
aminosalicylates
prednisone
mercaptopurine
budesonide
Woodholme Gastroenterology
 (6.7 away) Contact site
  • 0 views
  • 07 Oct, 2020
  • +293 other locations
Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

marginal zone lymphoma
bendamustine
stem cell transplantation
mantle cell lymphoma
hodgkin's disease
TG Therapeutics Investigational Trial Site
 (7.6 away) Contact site
  • 0 views
  • 11 Nov, 2020
  • +200 other locations
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

This randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast cancer previously treated with chemotherapy and surgery. Lymph node dissection may remove cancer cells that have spread to nearby lymph nodes in …

anthracyclines
estrogen receptor
sentinel node
ductal carcinoma in situ
tumor cells
Northwest Hospital Center
 (3.8 away) Contact site
  • 476 views
  • 22 Nov, 2020
  • +690 other locations
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

This phase III trial studies response-based chemotherapy in treating newly diagnosed acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by …

trisomy
cancer
leukemia
cytarabine
etoposide
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 153 views
  • 27 Sep, 2020
  • +133 other locations
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

This randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

estrogen receptor
thyroid-stimulating hormone
invasive cancer
tumor cells
triple-negative breast cancer
University of Maryland Saint Joseph Medical Center
 (7.6 away) Contact site
  • 1080 views
  • 29 Nov, 2020
  • +612 other locations
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

This phase III trial studies iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Crizotinib may stop the growth of tumor cells by blocking …

iobenguane
topotecan
conventional surgery
stem cell transplantation
tumor cells
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 66 views
  • 29 Nov, 2020
  • +95 other locations